Displaying items by tag: school of medicine

Blue Cross Blue Shield of Alabama has given the University of Alabama at Birmingham School of Medicine a $3.6 million scholarship to fund tuition for 60 primary care medical students over the course of five years.
Cardiovascular physicians at UAB are providing new services for cancer patients and survivors who develop heart complications during and after treatment.
A neuron model of Parkinson’s disease and Lewy body dementias shows defects that could suggest treatments to halt or reverse cognitive impairments before the neurons die.
The UAB-led clinical trial intends to provide multiple myeloma patients a treatment plan that eradicates their disease and enables them to live a life without ongoing treatment.
Frances Lund highlighted the need to do drug trials where the concentrations of inflammatory diseases are highest — the Southeast.
mediKanren, an "analytic engine" designed by UAB researchers, can sift 97 million assertions in seconds to find new treatments for patients and research avenues for scientists.
Kidney transplant recipients used to have to come to UAB for their post-transplant appointments. But thanks to telehealth, they no longer have to travel long distances to see their doctors.
The All of Us Research Program, an effort by the NIH to build a national database for medical research, launches on May 6 at UAB and six other sites nation-wide.
Medicare and Medicaid beneficiaries with end-stage heart failure seeking OHT and LVAD implantation will be drastically affected if the proposed cuts are implemented, according to UAB research.
A UAB professor has been named the Ronald McDonald House Charities of Alabama Young Professional of the Year.
Riding bicycles is a fun and healthy way to get around efficiently. Know the rules and keep yourself safe while riding.
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients.

Constraint-Induced Therapy, developed as a rehabilitation technique following stroke, appears beneficial for patients with multiple sclerosis, according to new findings from UAB.

CNine Biosolutions is moving toward clinical testing of its UAB-licensed technology.
Megan Gagliardi is thankful to have a physical reminder of her heart transplant to reflect on each day. “I love my scar, and I love showing people what I’ve been through. It’s a huge part of me.”
Page 95 of 170